Phaninc Exchange:Depression And Alzheimer's Treatments At A Crossroads

2025-04-30 15:29:58source:Cyprusauction Trading Centercategory:reviews

Researchers are Phaninc Exchangelaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:reviews

Recommend

Appeals court scraps Nasdaq boardroom diversity rules in latest DEI setback

A federal appeals court blocked Nasdaq rules to increase boardroom diversity, saying that the Securi

What to know about judge’s ruling allowing Fani Willis to stay on Trump’s Georgia election case

ATLANTA (AP) — Fulton County District Attorney Fani Willis can prosecute Donald Trump on charges tha

A ‘Gassy’ Alabama Coal Mine Was Expanding Under a Family’s Home. After an Explosion, Two Were Left Critically Injured

ADGER, Ala.—He’d said he thought his home would explode. He was right. W.M. Griffice, 78, had told h